The Medicines and Healthcare products Regulatory Agency (MHRA), which is responsible for licensing medicines in the UK, has not granted approval for retatrutide
The market for these therapies is on the brink of major expansion, with projections suggesting that the number of GLP-1 patients worldwide will more than double between 2025 and 2029
It's a simple habit that can significantly reduce your daily added sugar intake over time
Weight loss varies by medication, dose, adherence, side effects, nutrition, activity, sleep, and medical history
At Ledisa, we are committed to science-backed, ingredient-based wellness solutions that work in harmony with your body